CoverageForm 410-K10-Q8-K13D13G13F

LH Laboratory Corp of America Holdings - 8-K

Filed May 27, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0000920148-26-000147
7.019.01

Item 7.01 - Regulation FD Disclosure

110 words

Item 7.01.

Regulation FD Disclosure.

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on May 27, 2026, that the Company will present at the 2026 Jefferies Healthcare Conference in New York on Wednesday, June 3, from 12:15 pm to 12:45 pm ET. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein.

The presentation can be accessed via a live webcast on the Labcorp Investor Relations website at ir.labcorp.com. An archived, recorded version of the session will be available approximately 24 hours after the session ends and can be accessed for 90 days following the event.

Item 9.01 - Financial Statements and Exhibits

35 words

Item 9.01.

Financial Statements and Exhibits.

Exhibit

Exhibit Name

Exhibit 99.1

Press Release dated May 27, 2026 issued by Labcorp Holdings Inc.

Exhibit 104

Cover Page Interactive Data File (embedded within the Inline XBRL document)